MonumenTAL-8
A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
Arms / Cohorts
Experimental - RRMM:Cohort 1: Cilta-cel + Talquetamab Consolidation Post Chimeric Antigen Receptor T cell (CAR-T)Therapy
Not yet accepting
Experimental - NDMM:Cohort 2: Cilta-cel + Talquetamab Consolidation Post CAR-T Therapy
Not yet accepting
Experimental - RRMM:Cohort 3: Tal Bridging Therapy Pre-CAR-T Therapy + Cilta-cel
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.